Literature DB >> 28620655

A Commentary on Attitudes Towards Deep Brain Stimulation for Addiction.

Karen E Lee1, Mahendra T Bhati1, Casey H Halpern1.   

Abstract

Deep brain stimulation (DBS) has proven to be an effective treatment for neurologic disorders such as Parkinson's disease, and is currently being investigated as a therapy for psychiatric diseases such as addiction, major depressive disorder, and obsessive compulsive disorder. In this commentary, we review and discuss the findings presented in the Letter to the Editor entitled "Attitudes towards treating addiction with deep brain stimulation," written by Ali et al1. The survey presented in this Letter reported general approval for examining the effects of DBS on addictive disorders in a clinical trial, but highlighted critical areas of concern including informed consent, patient autonomy, appropriate medical practice, passing of clinical trial milestones, and implications on law enforcement.

Entities:  

Keywords:  DBS; addiction; clinical trials; ethics; informed consent; patient autonomy

Year:  2016        PMID: 28620655      PMCID: PMC5469439          DOI: 10.29245/2572.942x/2016/8.1093

Source DB:  PubMed          Journal:  J Neurol Neuromedicine        ISSN: 2572-942X


  13 in total

1.  Ethical issues surrounding forced, mandated, or coerced treatment.

Authors:  Arthur L Caplan
Journal:  J Subst Abuse Treat       Date:  2006-08-02

Review 2.  Deep brain stimulation of the nucleus accumbens for the treatment of addiction.

Authors:  Ulf J Müller; Jürgen Voges; Johann Steiner; Imke Galazky; Hans-Jochen Heinze; Michaela Möller; Jared Pisapia; Casey Halpern; Arthur Caplan; Bernhard Bogerts; Jens Kuhn
Journal:  Ann N Y Acad Sci       Date:  2012-12-10       Impact factor: 5.691

3.  Attitudes Toward Treating Addiction With Deep Brain Stimulation.

Authors:  Rohaid Ali; Matthew F DiFrancesco; Allen L Ho; Kyle M Kampman; Arthur L Caplan; Casey H Halpern
Journal:  Brain Stimul       Date:  2016-03-15       Impact factor: 8.955

Review 4.  Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.

Authors:  James H Stephen; Casey H Halpern; Cristian J Barrios; Usha Balmuri; Jared M Pisapia; John A Wolf; Kyle M Kampman; Gordon H Baltuch; Arthur L Caplan; Sherman C Stein
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

Review 5.  Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management.

Authors:  Casey H Halpern; Napoleon Torres; Howard I Hurtig; John A Wolf; James Stephen; Michael Y Oh; Noel N Williams; Marc A Dichter; Jurg L Jaggi; Arthur L Caplan; Kyle M Kampman; Thomas A Wadden; Donald M Whiting; Gordon H Baltuch
Journal:  Acta Neurochir (Wien)       Date:  2011-12       Impact factor: 2.216

Review 6.  Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets.

Authors:  Michael S Okun; Kelly D Foote
Journal:  Expert Rev Neurother       Date:  2010-12       Impact factor: 4.618

7.  Amelioration of binge eating by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation.

Authors:  Casey H Halpern; Anand Tekriwal; Jessica Santollo; Jeffrey G Keating; John A Wolf; Derek Daniels; Tracy L Bale
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

8.  Me, Myself and My Brain Implant: Deep Brain Stimulation Raises Questions of Personal Authenticity and Alienation.

Authors:  Felicitas Kraemer
Journal:  Neuroethics       Date:  2011-05-12       Impact factor: 1.480

9.  Deep Brain Stimulation and the Search for Identity.

Authors:  Karsten Witt; Jens Kuhn; Lars Timmermann; Mateusz Zurowski; Christiane Woopen
Journal:  Neuroethics       Date:  2011-02-16       Impact factor: 1.480

Review 10.  Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Authors:  P Justin Rossi; Aysegul Gunduz; Jack Judy; Linda Wilson; Andre Machado; James J Giordano; W Jeff Elias; Marvin A Rossi; Christopher L Butson; Michael D Fox; Cameron C McIntyre; Nader Pouratian; Nicole C Swann; Coralie de Hemptinne; Robert E Gross; Howard J Chizeck; Michele Tagliati; Andres M Lozano; Wayne Goodman; Jean-Philippe Langevin; Ron L Alterman; Umer Akbar; Greg A Gerhardt; Warren M Grill; Mark Hallett; Todd Herrington; Jeffrey Herron; Craig van Horne; Brian H Kopell; Anthony E Lang; Codrin Lungu; Daniel Martinez-Ramirez; Alon Y Mogilner; Rene Molina; Enrico Opri; Kevin J Otto; Karim G Oweiss; Yagna Pathak; Aparna Shukla; Jonathan Shute; Sameer A Sheth; Ludy C Shih; G Karl Steinke; Alexander I Tröster; Nora Vanegas; Kareem A Zaghloul; Leopoldo Cendejas-Zaragoza; Leonard Verhagen; Kelly D Foote; Michael S Okun
Journal:  Front Neurosci       Date:  2016-04-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.